Permira funds to acquire leading European CNS specialty pharmaceutical company Neuraxpharm
22/09/2020 Press release PERMIRA FUNDS TO ACQUIRE LEADING EUROPEAN CNS SPECIALTY PHARMACEUTICAL COMPANY NEURAXPHARM. Permira, the global private equity firm, today announced that a company backed by the Permira funds has agreed to acquire Neuraxpharm, a leading European specialty pharmaceutical company focused on the treatment of the central nervous system (CNS) from funds advised by…